Blog and newsletters!
Dr. Thierry Olivry’s Point of View | January 2021
by Dr. Thierry Olivry’s Point of View on January 12, 2021 at 11:00 am
What should I choose: intradermal testing or IgE serology? Dear Colleagues,
Dr. Thierry Olivry’s Point of View | December 2020
by Dr. Thierry Olivry’s Point of View on January 11, 2021 at 8:23 pm
Continuing allergen immunotherapy for longer than one year should lead to a higher treatment success! To ensure the maintenance of the readership’s interest, I propose to occasionally change the format of these monthly newsletters while still maintaining a “ˆbest-evidence” approach.
Spectrum Is Now Nextmune
by Nextmune News on January 4, 2021 at 4:00 pm
Starting January 4th, 2021, we will have a new name, a new brand, a new logo, and a new website. We appreciate your patience during this transition.
Dr. Thierry Olivry’s Point of View | November 2020
by Dr. Thierry Olivry’s Point of View on December 8, 2020 at 7:00 am
When is the best time to do allergen-specific IgE serological testing? This question is commonly asked by veterinarians to Nextmune colleagues, and I could simply reply that there are no studies in the literature that unequivocally address this question.
New Things Are Coming In 2021!
by Spectrum Veterinary Staff on November 30, 2020 at 4:50 pm
Our company is developing, improving and restructuring faster than ever. Our goal, as always, is to guarantee we bring you the best-in-class service, products, support and digital tools. 2021 will be an important milestone for us and we look forward to celebrate and share it with you.
Dr. Thierry Olivry’s Point of View | October 2020
by Dr. Thierry Olivry’s Point of View on November 25, 2020 at 5:45 pm
Can I perform IgE serology or intradermal testing when my patient is treated with glucocorticoids, cyclosporine, oclacitinib, or lokivetmab? This question is highly relevant to daily veterinary practice, as most pets with active clinical signs are already treated with anti-allergic drugs by the time the discussion arises whether or not to test for IgE sensitivities before starting allergen immunotherapy.
CCDs & Their Role in Allergy Diagnostics
by Spectrum Veterinary Staff on August 28, 2020 at 5:50 pm
What are CCDs?
by Spectrum Veterinary Staff on July 6, 2020 at 4:38 pm
Well, 2020 has been quite the year so far. While the data indicates many veterinary practices are on the road to recovery we still have a bit of uncertainty looming. Spectrum wanted to use this time to fast track some long-needed improvements to our lab tracking system that was just completed July 6th. These new improvements are the framework that will allow us to add more clinic and pet parent functionality in the future. We are very excited and sincerely appreciate our clinic’s patients during this transition.
Allergy Management Tips And Tricks
by Spectrum Veterinary Staff on June 1, 2020 at 4:36 pm
Allergies are triggered by diverse environmental, dietary, and seasonal factors. Although hyposensitization therapy is often the best option to clear up an allergy, there are many ways to reduce symptoms and increase treatment effectiveness. It should be noted that, although these tips and tricks will decrease allergy symptoms, they alone cannot be the only treatment option. Best results are observed when these tips and tricks are used concurrently with hyposensitization therapy.
Managing Allergies In The Wake of COVID-19
by Spectrum Veterinary Staff on May 5, 2020 at 8:00 am
COVID-19: The Impact Health officials across the U.S. and all over the world are working hard to combat COVID-19. For veterinarians, this work includes providing care for pets: horses, livestock, laboratory animals, aquatic, exotic, and wild animals – all work that is essential and helps protect both animal and human health. Practices have had to put plans in place to protect their team, minimize exposure for staff and pet parents. They have had to scrounge to find personal protective equipment that even human medical professionals have struggled to find. But recent clinic data has shown some positive indications that leave some cautiously optimistic about the state of the industry.